Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Konica Minolta ( (JP:4902) ) just unveiled an update.
Konica Minolta reported a return to solid profitability for the nine months ended December 31, 2025, despite a 6.1% year-on-year decline in revenue to ¥781.1 billion, reflecting the exclusion of its Precision Medicine Business, now classified as a discontinued operation. Business contribution profit rose 20.5% to ¥34.7 billion and operating profit swung from a loss of ¥18.5 billion in the prior-year period to a profit of ¥33.3 billion, while profit attributable to owners reached ¥21.4 billion, translating into basic earnings per share of ¥43.38 versus a loss per share a year earlier. The company’s financial position also strengthened, with equity attributable to owners increasing to ¥519.7 billion and the equity ratio improving to 42.5% from 38.0% at the March 2025 year-end, and Konica Minolta reinstated shareholder returns via an interim dividend of ¥5 per share and a full-year dividend forecast of ¥10 per share, signaling confidence in its earnings recovery and balance sheet health.
The most recent analyst rating on (JP:4902) stock is a Hold with a Yen620.00 price target. To see the full list of analyst forecasts on Konica Minolta stock, see the JP:4902 Stock Forecast page.
More about Konica Minolta
Konica Minolta, Inc. is a Japan-based technology company listed on the Tokyo Stock Exchange Prime Market. The company operates primarily in imaging, optics and related digital solutions, with businesses spanning office equipment, industrial and healthcare-related fields, and it prepares its consolidated financial statements under IFRS standards.
Average Trading Volume: 3,123,003
Technical Sentiment Signal: Buy
Current Market Cap: Yen328.9B
For a thorough assessment of 4902 stock, go to TipRanks’ Stock Analysis page.